Brainstorm Cell Therapeutics Submits Special Protocol Assess

Brainstorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request To FDA For Phase 3B Trial Of Nurown® In ALS

Brainstorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request To FDA For Phase 3B Trial Of Nurown® In ALS

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California , United States , Chaim Lebovits , Lisa Guiterman , Stacy Lindborg , Brainstorm Cell Therapeutics Inc , Drug Administration , Nasdaq , National Ms Society , European Medicines Agency , California Institute For Regenerative Medicine , Prnewswire Brainstorm Cell Therapeutics Inc , Storm Cell Therapeutics , Special Protocol Assessment , Chief Executive Officer , Floor Effect , Orphan Drug , California Institute , Regenerative Medicine ,